784 related articles for article (PubMed ID: 29138302)
1. Disruption of the Opal Stop Codon Attenuates Chikungunya Virus-Induced Arthritis and Pathology.
Jones JE; Long KM; Whitmore AC; Sanders W; Thurlow LR; Brown JA; Morrison CR; Vincent H; Peck KM; Browning C; Moorman N; Lim JK; Heise MT
mBio; 2017 Nov; 8(6):. PubMed ID: 29138302
[TBL] [Abstract][Full Text] [Related]
2. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
[TBL] [Abstract][Full Text] [Related]
3. Chikungunya Virus Overcomes Polyamine Depletion by Mutation of nsP1 and the Opal Stop Codon To Confer Enhanced Replication and Fitness.
Mounce BC; Cesaro T; Vlajnić L; Vidiņa A; Vallet T; Weger-Lucarelli J; Passoni G; Stapleford KA; Levraud JP; Vignuzzi M
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539441
[TBL] [Abstract][Full Text] [Related]
4. A structural and functional analysis of opal stop codon translational readthrough during Chikungunya virus replication.
Li R; Sun K; Tuplin A; Harris M
J Gen Virol; 2023 Oct; 104(10):. PubMed ID: 37862073
[TBL] [Abstract][Full Text] [Related]
5. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology.
Teo TH; Her Z; Tan JJ; Lum FM; Lee WW; Chan YH; Ong RY; Kam YW; Leparc-Goffart I; Gallian P; Rénia L; de Lamballerie X; Ng LF
J Virol; 2015 Aug; 89(15):7955-69. PubMed ID: 25995257
[TBL] [Abstract][Full Text] [Related]
6. Effects of an opal termination codon preceding the nsP4 gene sequence in the O'Nyong-Nyong virus genome on Anopheles gambiae infectivity.
Myles KM; Kelly CL; Ledermann JP; Powers AM
J Virol; 2006 May; 80(10):4992-7. PubMed ID: 16641290
[TBL] [Abstract][Full Text] [Related]
7. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
Akhrymuk I; Lukash T; Frolov I; Frolova EI
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
[TBL] [Abstract][Full Text] [Related]
8. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
[TBL] [Abstract][Full Text] [Related]
10. Using SHAPE-MaP To Model RNA Secondary Structure and Identify 3'UTR Variation in Chikungunya Virus.
Madden EA; Plante KS; Morrison CR; Kutchko KM; Sanders W; Long KM; Taft-Benz S; Cruz Cisneros MC; White AM; Sarkar S; Reynolds G; Vincent HA; Laederach A; Moorman NJ; Heise MT
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999019
[TBL] [Abstract][Full Text] [Related]
11. A Chikungunya Virus
Bartholomeeusen K; Utt A; Coppens S; Rausalu K; Vereecken K; Ariën KK; Merits A
J Virol; 2018 Jul; 92(14):. PubMed ID: 29695432
[TBL] [Abstract][Full Text] [Related]
12. Multiple Host Factors Interact with the Hypervariable Domain of Chikungunya Virus nsP3 and Determine Viral Replication in Cell-Specific Mode.
Meshram CD; Agback P; Shiliaev N; Urakova N; Mobley JA; Agback T; Frolova EI; Frolov I
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899097
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the Role of E2 Protein Domains in Alphavirus Pathogenicity.
Weger-Lucarelli J; Aliota MT; Wlodarchak N; Kamlangdee A; Swanson R; Osorio JE
J Virol; 2015 Dec; 90(5):2418-33. PubMed ID: 26676771
[TBL] [Abstract][Full Text] [Related]
14. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.
Issac TH; Tan EL; Chu JJ
J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005
[TBL] [Abstract][Full Text] [Related]
15. Chikungunya Virus Evades Antiviral CD8
Davenport BJ; Bullock C; McCarthy MK; Hawman DW; Murphy KM; Kedl RM; Diamond MS; Morrison TE
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102875
[TBL] [Abstract][Full Text] [Related]
16. Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.
Acharya D; Paul AM; Anderson JF; Huang F; Bai F
PLoS Negl Trop Dis; 2015; 9(10):e0004139. PubMed ID: 26484530
[TBL] [Abstract][Full Text] [Related]
17. NAP1L1 and NAP1L4 Binding to Hypervariable Domain of Chikungunya Virus nsP3 Protein Is Bivalent and Requires Phosphorylation.
Dominguez F; Shiliaev N; Lukash T; Agback P; Palchevska O; Gould JR; Meshram CD; Prevelige PE; Green TJ; Agback T; Frolova EI; Frolov I
J Virol; 2021 Jul; 95(16):e0083621. PubMed ID: 34076483
[TBL] [Abstract][Full Text] [Related]
18. Conserved motifs in the hypervariable domain of chikungunya virus nsP3 required for transmission by Aedes aegypti mosquitoes.
Göertz GP; Lingemann M; Geertsema C; Abma-Henkens MHC; Vogels CBF; Koenraadt CJM; van Oers MM; Pijlman GP
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006958. PubMed ID: 30412583
[TBL] [Abstract][Full Text] [Related]
19. Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription.
Utt A; Rausalu K; Jakobson M; Männik A; Alphey L; Fragkoudis R; Merits A
J Virol; 2019 Sep; 93(18):. PubMed ID: 31217251
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
